These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20537745)

  • 1. Autoantibodies found in type-2 diabetes with AIT test may be associated with its nephropathic complication.
    Park EY; Kim TY
    Diabetes Res Clin Pract; 2010 Oct; 90(1):e3-4. PubMed ID: 20537745
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?
    Arababadi MK; Nosratabadi R; Hassanshahi G; Yaghini N; Pooladvand V; Shamsizadeh A; Hakimi H; Derakhshan R
    Diabetes Res Clin Pract; 2010 Jan; 87(1):33-7. PubMed ID: 19875190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of glomerulonephritis and autoantibodies in diabetes mellitus.
    Bhuyan UN; Dash SC; Srikanta S; Malaviya AN; Malhotra KK
    J Assoc Physicians India; 1984 Feb; 32(2):171-5. PubMed ID: 6235208
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of anti-glomerular basement membrane antibodies in type 2 diabetic patients.
    Aziz KA
    Saudi Med J; 2006 Jun; 27(6):915. PubMed ID: 16758072
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-tube test for autoantibodies to glutamic acid decarboxylase and proinsulin as first-line screening for autoimmunity in adult-onset diabetic patients.
    Valdez SN; Villalba A; Iacono RF; Poskus E
    Clin Immunol; 2004 Dec; 113(3):241-7. PubMed ID: 15507388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD38 autoantibodies in type? diabetes.
    Mallone R; Perin PC
    Diabetes Metab Res Rev; 2006; 22(4):284-94. PubMed ID: 16544364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes, nephropathy and HLA.
    Thompson CF
    N Z Med J; 1999 Feb; 112(1081):41. PubMed ID: 10078216
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid autoimmunity in children with features of both type 1 and type 2 diabetes.
    Libman IM; Sun K; Foley TP; Becker DJ
    Pediatr Diabetes; 2008 Jul; 9(4 Pt 1):266-71. PubMed ID: 18466208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-immunologic aspects of diabetes mellitus].
    Esenin VI; Zlobina EN; Demin IuM; Dedov II
    Sov Med; 1990; (3):100-1. PubMed ID: 2195666
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in the role of autoantibodies in diabetic nephropathy: Review].
    Zhou Z; Luo R; Wan Z; Kuang H; Lyu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Feb; 36(2):175-179. PubMed ID: 32314716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.
    Leinonen JS; Rantalaiho V; Laippala P; Wirta O; Pasternack A; Alho H; Jaakkola O; Ylä-Herttuala S; Koivula T; Lehtimäki T
    Free Radic Res; 1998 Aug; 29(2):137-41. PubMed ID: 9790515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological aspects of the development of diabetes mellitus and its complications].
    Kamaeva OI
    Ter Arkh; 1994; 66(10):14-7. PubMed ID: 7863435
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of anti-glomerular basement membrane antibodies in type 2 diabetic patients.
    Noorwali A
    Saudi Med J; 2005 Nov; 26(11):1734-6. PubMed ID: 16311657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmunity and diabetes mellitus. Recent developments].
    Bastenie PA
    Bull Acad Natl Med; 1979 Jan; 163(1):49-54; discussion 54. PubMed ID: 15666639
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.